Blood Stream Infection Testing-Global Market Status and Trend Report 2013-2023

SKU ID :MI-11931724 | Published Date: 04-Apr-2018 | No. of pages: 147
Table of Contents Chapter 1 Overview of Blood Stream Infection Testing 1.1 Definition of Blood Stream Infection Testing in This Report 1.2 Commercial Types of Blood Stream Infection Testing 1.2.1 Instruments 1.2.2 Consumables 1.3 Downstream Application of Blood Stream Infection Testing 1.3.1 Hospitals 1.3.2 Diagnostics Clinical Laboratories 1.3.3 Other 1.4 Development History of Blood Stream Infection Testing 1.5 Market Status and Trend of Blood Stream Infection Testing 2013-2023 1.5.1 Global Blood Stream Infection Testing Market Status and Trend 2013-2023 1.5.2 Regional Blood Stream Infection Testing Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Blood Stream Infection Testing 2013-2017 2.2 Production Market of Blood Stream Infection Testing by Regions 2.2.1 Production Volume of Blood Stream Infection Testing by Regions 2.2.2 Production Value of Blood Stream Infection Testing by Regions 2.3 Demand Market of Blood Stream Infection Testing by Regions 2.4 Production and Demand Status of Blood Stream Infection Testing by Regions 2.4.1 Production and Demand Status of Blood Stream Infection Testing by Regions 2013-2017 2.4.2 Import and Export Status of Blood Stream Infection Testing by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Blood Stream Infection Testing by Types 3.2 Production Value of Blood Stream Infection Testing by Types 3.3 Market Forecast of Blood Stream Infection Testing by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Blood Stream Infection Testing by Downstream Industry 4.2 Market Forecast of Blood Stream Infection Testing by Downstream Industry Chapter 5 Market Driving Factor Analysis of Blood Stream Infection Testing 5.1 Global Economy Situation and Trend Overview 5.2 Blood Stream Infection Testing Downstream Industry Situation and Trend Overview Chapter 6 Blood Stream Infection Testing Market Competition Status by Major Manufacturers 6.1 Production Volume of Blood Stream Infection Testing by Major Manufacturers 6.2 Production Value of Blood Stream Infection Testing by Major Manufacturers 6.3 Basic Information of Blood Stream Infection Testing by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Blood Stream Infection Testing Major Manufacturer 6.3.2 Employees and Revenue Level of Blood Stream Infection Testing Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Blood Stream Infection Testing Major Manufacturers Introduction and Market Data 7.1 BD Medical 7.1.1 Company profile 7.1.2 Representative Blood Stream Infection Testing Product 7.1.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BD Medical 7.2 Thermo Fisher Scientific 7.2.1 Company profile 7.2.2 Representative Blood Stream Infection Testing Product 7.2.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 7.3 BioMerieux 7.3.1 Company profile 7.3.2 Representative Blood Stream Infection Testing Product 7.3.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BioMerieux 7.4 Cepheid 7.4.1 Company profile 7.4.2 Representative Blood Stream Infection Testing Product 7.4.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Cepheid 7.5 Roche Diagnostics 7.5.1 Company profile 7.5.2 Representative Blood Stream Infection Testing Product 7.5.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Roche Diagnostics 7.6 Abbott Molecular 7.6.1 Company profile 7.6.2 Representative Blood Stream Infection Testing Product 7.6.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Abbott Molecular 7.7 Beckman Coulter 7.7.1 Company profile 7.7.2 Representative Blood Stream Infection Testing Product 7.7.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Beckman Coulter 7.8 Siemens 7.8.1 Company profile 7.8.2 Representative Blood Stream Infection Testing Product 7.8.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Siemens 7.9 Alere 7.9.1 Company profile 7.9.2 Representative Blood Stream Infection Testing Product 7.9.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Alere 7.10 Bruker 7.10.1 Company profile 7.10.2 Representative Blood Stream Infection Testing Product 7.10.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Bruker 7.11 AB Sciex 7.11.1 Company profile 7.11.2 Representative Blood Stream Infection Testing Product 7.11.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AB Sciex 7.12 Nanosphere 7.12.1 Company profile 7.12.2 Representative Blood Stream Infection Testing Product 7.12.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Nanosphere 7.13 Eurogentec 7.13.1 Company profile 7.13.2 Representative Blood Stream Infection Testing Product 7.13.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Eurogentec 7.14 AdvanDX 7.14.1 Company profile 7.14.2 Representative Blood Stream Infection Testing Product 7.14.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AdvanDX 7.15 Dade Behring 7.15.1 Company profile 7.15.2 Representative Blood Stream Infection Testing Product 7.15.3 Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Dade Behring Chapter 8 Upstream and Downstream Market Analysis of Blood Stream Infection Testing 8.1 Industry Chain of Blood Stream Infection Testing 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Blood Stream Infection Testing 9.1 Cost Structure Analysis of Blood Stream Infection Testing 9.2 Raw Materials Cost Analysis of Blood Stream Infection Testing 9.3 Labor Cost Analysis of Blood Stream Infection Testing 9.4 Manufacturing Expenses Analysis of Blood Stream Infection Testing Chapter 10 Marketing Status Analysis of Blood Stream Infection Testing 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference
List of Tables Table Advantage and Disadvantage of Instruments Table Advantage and Disadvantage of Consumables Table Production Volume of Blood Stream Infection Testing by Regions 2013-2017 Table Production Value of Blood Stream Infection Testing by Regions 2013-2017 Table Demand Volume of Blood Stream Infection Testing by Regions 2013-2017 Table Production and Demand Status of Blood Stream Infection Testing in Region One 2013-2017 Table Production and Demand Status of Blood Stream Infection Testing in Region Two 2013-2017 Table Production and Demand Status of Blood Stream Infection Testing in Region Three 2013-2017 Table Production and Demand Status of Blood Stream Infection Testing in Region Four 2013-2017 Table Import Volume of Blood Stream Infection Testing by Regions 2013-2017 Table Export Volume of Blood Stream Infection Testing by Regions 2013-2017 Table Production Volume of Blood Stream Infection Testing by Types 2013-2017 Table Production Value of Blood Stream Infection Testing by Types 2013-2017 Table Production Volume Forecast of Blood Stream Infection Testing by Types 2018-2023 Table Production Value Forecast of Blood Stream Infection Testing by Types 2018-2023 Table Demand Volume of Blood Stream Infection Testing by Downstream Industry 2013-2017 Table Demand Volume Forecast of Blood Stream Infection Testing by Downstream Industry 2018-2023 Table Production Volume of Blood Stream Infection Testing by Major Manufacturers 2013-2017 Table Production Value of Blood Stream Infection Testing by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Blood Stream Infection Testing Major Manufacturer Table Employees and Revenue Level of Blood Stream Infection Testing Major Manufacturer Table Representative Blood Stream Infection Testing Product One of BD Medical Table Representative Blood Stream Infection Testing Product Two of BD Medical Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BD Medical 2013-2017 Table Representative Blood Stream Infection Testing Product One of Thermo Fisher Scientific Table Representative Blood Stream Infection Testing Product Two of Thermo Fisher Scientific Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific 2013-2017 Table Representative Blood Stream Infection Testing Product One of BioMerieux Table Representative Blood Stream Infection Testing Product Two of BioMerieux Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of BioMerieux 2013-2017 Table Representative Blood Stream Infection Testing Product One of Cepheid Table Representative Blood Stream Infection Testing Product Two of Cepheid Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Cepheid 2013-2017 Table Representative Blood Stream Infection Testing Product One of Roche Diagnostics Table Representative Blood Stream Infection Testing Product Two of Roche Diagnostics Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Roche Diagnostics 2013-2017 Table Representative Blood Stream Infection Testing Product One of Abbott Molecular Table Representative Blood Stream Infection Testing Product Two of Abbott Molecular Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Abbott Molecular 2013-2017 Table Representative Blood Stream Infection Testing Product One of Beckman Coulter Table Representative Blood Stream Infection Testing Product Two of Beckman Coulter Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Beckman Coulter 2013-2017 Table Representative Blood Stream Infection Testing Product One of Siemens Table Representative Blood Stream Infection Testing Product Two of Siemens Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Siemens 2013-2017 Table Representative Blood Stream Infection Testing Product One of Alere Table Representative Blood Stream Infection Testing Product Two of Alere Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Alere 2013-2017 Table Representative Blood Stream Infection Testing Product One of Bruker Table Representative Blood Stream Infection Testing Product Two of Bruker Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Bruker 2013-2017 Table Representative Blood Stream Infection Testing Product One of AB Sciex Table Representative Blood Stream Infection Testing Product Two of AB Sciex Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AB Sciex 2013-2017 Table Representative Blood Stream Infection Testing Product One of Nanosphere Table Representative Blood Stream Infection Testing Product Two of Nanosphere Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Nanosphere 2013-2017 Table Representative Blood Stream Infection Testing Product One of Eurogentec Table Representative Blood Stream Infection Testing Product Two of Eurogentec Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Eurogentec 2013-2017 Table Representative Blood Stream Infection Testing Product One of AdvanDX Table Representative Blood Stream Infection Testing Product Two of AdvanDX Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of AdvanDX 2013-2017 Table Representative Blood Stream Infection Testing Product One of Dade Behring Table Representative Blood Stream Infection Testing Product Two of Dade Behring Table Blood Stream Infection Testing Sales, Revenue, Price and Gross Margin of Dade Behring 2013-2017
  • PRICE
  • $2980
    $4480

Our Clients